Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
synthonicsinc.com

See what CB Insights has to offer

Stage

Corporate Minority | Alive

Total Raised

$7.97M

Last Raised

$2M | 7 yrs ago

About Synthonics

Synthonics is a specialty pharmaceutical company focused on the discovery, development and licensing of drugs that incorporate our proprietary metal coordination chemistry. Metal coordination entails attaching a pharmaceutically acceptable metal, such as zinc, bismuth or magnesium, to a known pharmaceutical agent to create a new and more effective drug. The addition of the metal changes the way the drug is absorbed or delivered without altering the action of the underlying drug.

Synthonics Headquarter Location

2220 Kraft Drive Suite 2225

Blacksburg, Virginia, 24060,

United States

540-443-3645

Latest Synthonics News

Synthonics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250

Oct 6, 2018

00:42 EDT 6 Oct 2018 | BioPortfolio Reports Summary Synthonics Inc Synthonics is a pharmaceutical company that discovers, develops and licenses metal coordinated pharmaceuticals. The company uses unique metal coordination chemistry for modifying specific properties of patentexpiring pharmaceuticals. It develops MCP311, a drug candidate that provides solution to extend the absorption phase of levodopa using the bioadhesive properties of a bismuthlevodopa copolymer. Synthonics' patent applications include bismuthcontaining compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients; metal coordinated compositions; and coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients. The company works in partnership with other pharmaceutical companies to advance the development of novel drugs. Synthonics is headquartered in Blacksburg, Virginia, the US. Synthonics Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Synthonics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Synthonics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Synthonics Patents

Synthonics has filed 12 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Chlorides
  • Chloro complexes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/8/2010

12/11/2018

Glucocorticoids, Pregnanes, Abandoned drugs, Fluoroarenes, Monoclonal antibodies

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/8/2010

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/11/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Glucocorticoids, Pregnanes, Abandoned drugs, Fluoroarenes, Monoclonal antibodies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.